Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury
- 7 November 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 351 (4), 940-946
- https://doi.org/10.1016/j.bbrc.2006.10.166
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ST2 suppresses IL-6 production via the inhibition of IκB degradation induced by the LPS signal in THP-1 cellsBiochemical and Biophysical Research Communications, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Protective strategies against ischemic injury of the liverGastroenterology, 2003
- Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4Published by The American Association of Immunologists ,2002
- HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal PathwayJournal of Biological Chemistry, 2002
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4The Journal of Experimental Medicine, 2002
- A Novel Pathway Regulating Lipopolysaccharide-Induced Shock by ST2/T1 Via Inhibition of Toll-Like Receptor 4 ExpressionThe Journal of Immunology, 2001
- Mechanism of hepatocyte death after ischemia: Apoptosis versus necrosisHepatology, 2001
- T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector functionProceedings of the National Academy of Sciences of the United States of America, 1998
- Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T CellsThe Journal of Experimental Medicine, 1998